Grade 1‐2 neutropenia after first treatment for diffuse large B‐cell lymphoma is associated with a better outcome compared to grade 3‐4—A Danish population‐based cohort study. (June 2017) - Clausen, M.R.; Ulrichsen, S.P.; Nørgaard, M.; d'Amore, F.